Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
The following discussion and analysis presents factors that Motorcar Parts of America, Inc. and its subsidiaries (“our,” “we” or “us”) believe are relevant to an assessment and understanding of our consolidated financial position and results of operations. This financial and business analysis should be read in conjunction with our March 31, 2023 audited consolidated financial statements included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 14, 2023.
Disclosure Regarding Private Securities Litigation Reform Act of 1995
This report may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our future performance that involve risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, statements about our strategic initiatives, operational plans and objectives, expectations for economic conditions and recovery and future business and financial performance, as well as statements regarding underlying assumptions related thereto. They include, among others, factors related to the timing and implementation of strategic initiatives, the highly competitive nature of our industry, demand for our products and services, complexities in our inventory and supply chain, challenges with transforming and growing our business. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Therefore, you should not place undue reliance on those statements. Please refer to
“Item 1A. Risk Factors” of our most recent Annual Report on Form 10-K filed with the SEC on June 14, 2023, as updated by our subsequent filings with the SEC, for a description of these and other risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statements.
Management Overview
With a scalable infrastructure and abundant growth opportunities, we are focused on growing our aftermarket business in the North American marketplace and growing our leadership position in the test solutions and diagnostic equipment market by providing innovative and intuitive solutions to our customers. Our investments in infrastructure and human resources during the past few years reflects the significant expansion of manufacturing capacity to support multiple product lines. These investments included (i) a 410,000 square foot distribution center, (ii) two buildings totaling 372,000 square feet for remanufacturing and core sorting of brake calipers, and (iii) the realignment of production at our original 312,000 square foot facility in Mexico.
Segment Reporting
Effective as of the fourth quarter of fiscal 2023, we revised our segment reporting as we determined that our three operating segments no longer met the criteria to be aggregated. We recast our prior year segment disclosures to conform to the current year’s presentation.
Our three operating segments are as follows:
| • | Hard Parts, including (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors, brake pads and brake master cylinders, and (iv) turbochargers, |
| • | Test Solutions and Diagnostic Equipment, including (i) applications for combustion engine vehicles, including bench top testers for alternators and starters, (ii) equipment for the pre- and post-production of electric vehicles, and (iii) software emulation of power system applications for the electrification of all forms of transportation (including automobiles, trucks, the emerging electrification of systems within the aerospace industry, and electric vehicle charging stations), and |
| • | Heavy Duty, including non-discretionary automotive aftermarket replacement hard parts for heavy-duty truck, industrial, marine, and agricultural applications. |
Our Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, are not required to be separately reported, and are included within the “all other” category. See Note 17 of the notes to condensed consolidated financial statements for more information.
Results of Operations for the Three Months Ended December 31, 2023 and 2022
The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.
The following summarizes certain key consolidated operating data:
| | Three Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
Cash flow provided by (used in) operations | | $ | 53,615,000 | | | $ | (4,474,000 | ) |
Finished goods turnover (annualized) (1) | | | 3.6 | | | | 3.1 | |
| (1) | Annualized finished goods turnover for the fiscal quarter is calculated by multiplying cost of goods sold for the quarter by 4 and dividing the result by the average between beginning and ending non-core finished goods inventory values for the fiscal quarter. We believe this provides a useful measure of our ability to turn our inventory into revenues. |
Net Sales and Gross Profit
The following summarizes net sales and gross profit:
| | Three Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
Net sales | | $ | 171,862,000 | | | $ | 151,819,000 | |
Cost of goods sold | | | 141,819,000 | | | | 130,826,000 | |
Gross profit | | | 30,043,000 | | | | 20,993,000 | |
Gross profit percentage | | | 17.5 | % | | | 13.8 | % |
Net Sales. Our consolidated net sales for the three months ended December 31, 2023 were $171,862,000, which represents an increase of $20,043,000, or 13.2%, from the three months ended December 31, 2022 of $151,819,000. Our sales for the three months ended December 31, 2023 compared with the three months ended December 31, 2022 reflect strong demand across all product lines.
Gross Profit. Our consolidated gross profit was $30,043,000, or 17.5% of consolidated net sales, for the three months ended December 31, 2023 compared with $20,993,000, or 13.8% of consolidated net sales, for the three months ended December 31, 2022. The increase in our gross margin for the three months ended December 31, 2023 reflects increased utilization of our facilities and the benefit of price increases that went into effect during prior periods.
In addition, our gross margin for the three months ended December 31, 2023 compared with the three months ended December 31, 2022 was impacted by (i) additional expenses of $1,555,000 and $2,370,000, respectively, primarily due to certain costs for disruptions in the supply chain, (ii) amortization of core and finished goods premiums paid to customers related to new business of $2,838,000 and $3,075,000, respectively, and (iii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in a write-down of $1,607,000 and $863,000, respectively.
Operating Expenses
The following summarizes our consolidated operating expenses:
| | Three Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
General and administrative | | $ | 15,198,000 | | | $ | 13,599,000 | |
Sales and marketing | | | 5,931,000 | | | | 5,634,000 | |
Research and development | | | 2,539,000 | | | | 2,547,000 | |
Foreign exchange impact of lease liabilities and forward contracts | | | (3,149,000 | ) | | | (4,313,000 | ) |
| | | | | | | | |
Percent of net sales | | | | | | | | |
| | | | | | | | |
General and administrative | | | 8.8 | % | | | 9.0 | % |
Sales and marketing | | | 3.5 | % | | | 3.7 | % |
Research and development | | | 1.5 | % | | | 1.7 | % |
Foreign exchange impact of lease liabilities and forward contracts | | | (1.8 | )% | | | (2.8 | )% |
General and Administrative. Our general and administrative expenses for the three months ended December 31, 2023 were $15,198,000, which represents an increase of $1,599,000, or 11.8%, from the three months ended December 31, 2022 of $13,599,000. This increase was primarily for employee-related expenses, which included (i) $1,777,000 of increased employee incentives and (ii) $405,000 of increased share-based compensation expense in connection with equity grants made to employees. These increases were partially offset by $596,000 of decreased severance expense due to headcount reductions during the three months ended December 31, 2022.
Sales and Marketing. Our sales and marketing expenses for the three months ended December 31, 2023 were $5,931,000, which represents an increase of $297,000, or 5.3%, from the three months ended December 31, 2022 of $5,634,000. This increase was primarily due to increased employee-related expenses and higher commissions, which resulted from higher sales, partially offset by reduced expenses for trade shows during the three months ended December 31, 2023 compared with the three months ended December 31, 2022.
Research and Development. Our research and development expenses were consistent at $2,539,000 for the three months ended December 31, 2023 compared with $2,547,000 for the three months ended December 31, 2022.
Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts were non-cash gains of $3,149,000 and $4,313,000 for the three months ended December 31, 2023 and 2022, respectively. This change during the three months ended December 31, 2023 compared with the three months ended December 31, 2022 was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in non-cash gains of $2,608,000 and $3,129,000, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in non-cash gains of $541,000 and $1,184,000, respectively, due to the changes in their fair values.
Operating Income
Consolidated Operating Income. Our consolidated operating income for the three months ended December 31, 2023 was $9,524,000, which represents an increase of $5,998,000, or 170.1%, from the three months ended December 31, 2022 of $3,526,000. This increase was primarily due to higher sales and gross profit as discussed above.
Interest Expense
Interest Expense, net. Our interest expense for the three months ended December 31, 2023 was $18,297,000, which represents an increase of $6,826,000, or 59.5%, from interest expense for the three months ended December 31, 2022 of $11,471,000. This increase was primarily due to (i) increased utilization of and higher interest rates on our accounts receivable discount programs, which have variable interest rates and (ii) non-cash interest expense incurred on the Convertible Notes issued on March 31, 2023.
Change in Fair Value of Compound Net Derivative Liability
Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability for the three months ended December 31, 2023 was a non-cash loss of $1,160,000 associated with the convertible notes issued on March 31, 2023.
Loss on Extinguishment of Debt
Loss on Extinguishment of Debt. We did not incur any loss on extinguishment of debt during the three months ended December 31, 2023.
Provision for Income Taxes
Income Tax. We recorded an income tax expense of $37,281,000, or an effective tax rate of (375.3%), and an income tax benefit of $8,971,000, or an effective tax rate of 112.9%, for the three months ended December 31, 2023 and 2022, respectively. During the three months ended December 31, 2023, we recorded a discrete non-cash valuation allowance of $37,461,000 on our U.S. federal and various state deferred tax assets primarily due to recent losses. The change in the valuation allowance resulted from an updated forecast during the three months ended December 31, 2023. The effective tax rate for the three months ended December 31, 2023, was primarily impacted by (i) the establishment of a valuation allowance on deferred tax assets that we do not expect to be realized, (ii) foreign income taxed at rates that are different from the federal statutory rate, (iii) the portion of book expense related to convertible notes and derivatives that is not expected to be deductible for tax, and (iv) non-deductible executive compensation under Internal Revenue Code Section 162(m).
Results of Operations for the Nine Months Ended December 31, 2023 and 2022
The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.
The following summarizes certain key consolidated operating data:
| | Nine Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
Cash flow provided by (used in) operations | | $ | 48,445,000 | | | $ | (21,428,000 | ) |
Finished goods turnover (annualized) (1) | | | 3.7 | | | | 3.3 | |
| (1) | Annualized finished goods turnover for the fiscal period is calculated by multiplying cost of goods sold for the period by 1.33 and dividing the result by the average between beginning and ending non-core finished goods inventory values for the fiscal period. We believe this provides a useful measure of our ability to turn our inventory into revenues. |
Net Sales and Gross Profit
The following summarizes net sales and gross profit:
| | Nine Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
Net sales | | $ | 528,206,000 | | | $ | 488,347,000 | |
Cost of goods sold | | | 430,448,000 | | | | 410,536,000 | |
Gross profit | | | 97,758,000 | | | | 77,811,000 | |
Gross profit percentage | | | 18.5 | % | | | 15.9 | % |
Net Sales. Our consolidated net sales for the nine months ended December 31, 2023 were $528,206,000, which represents an increase of $39,859,000, or 8.2%, from the nine months ended December 31, 2022 of $488,347,000. Our sales for the nine months ended December 31, 2023 compared with the nine months ended December 31, 2022 increased due to strong demand across all product lines.
Gross Profit. Our consolidated gross profit was $97,758,000, or 18.5% of consolidated net sales, for the nine months ended December 31, 2023 compared with $77,811,000, or 15.9% of consolidated net sales, for the nine months ended December 31, 2022. The increase in our gross margin for the nine months ended December 31, 2023 reflects increased utilization of our facilities and the benefit of price increases that went into effect during prior periods.
In addition, our gross margin for the nine months ended December 31, 2023 compared with the nine months ended December 31, 2022 was impacted by (i) additional expenses of $6,738,000 and $5,282,000, respectively, primarily due to certain costs for disruptions in the supply chain, (ii) amortization of core and finished goods premiums paid to customers related to new business of $8,202,000 and $9,183,000, respectively, and (iii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in a write-down of $4,380,000 and $2,704,000, respectively.
Operating Expenses
The following summarizes consolidated operating expenses:
| | Nine Months Ended | |
| | December 31, | |
| | 2023 | | | 2022 | |
| | | | | | |
General and administrative | | $ | 42,125,000 | | | $ | 42,079,000 | |
Sales and marketing | | | 17,038,000 | | | | 17,242,000 | |
Research and development | | | 7,352,000 | | | | 8,330,000 | |
Foreign exchange impact of lease liabilities and forward contracts | | | (2,659,000 | ) | | | (2,553,000 | ) |
| | | | | | | | |
Percent of net sales | | | | | | | | |
| | | | | | | | |
General and administrative | | | 8.0 | % | | | 8.6 | % |
Sales and marketing | | | 3.2 | % | | | 3.5 | % |
Research and development | | | 1.4 | % | | | 1.7 | % |
Foreign exchange impact of lease liabilities and forward contracts | | | (0.5 | )% | | | (0.5 | )% |
General and Administrative. Our general and administrative expenses for the nine months ended December 31, 2023 were $42,125,000, which represents an increase of $46,000, or 0.1%, from the nine months ended December 31, 2022 of $42,079,000. This increase was primarily due to (i) $1,802,000 of increased employee incentives, (ii) $857,000 of increased professional services, and (iii) $747,000 of increased share-based compensation expense in connection with equity grants made to employees. These increases were partially offset by $901,000 of decreased severance and $672,000 of decreased employee-related expenses due to headcount reductions in the prior year. In addition, our general and administrative expenses for the nine months ended December 31, 2023 decreased due to fluctuations in foreign currency exchange rates compared with the prior year.
Sales and Marketing. Our sales and marketing expenses for the nine months ended December 31, 2023 were $17,038,000, which represents a decrease of $204,000, or 1.2%, from the nine months ended December 31, 2022 of $17,242,000. This decrease was primarily due to our cost-cutting measures, which included decreased marketing and advertising expenses, decreased trade show expenses, and decreased employee-related expenses. These decreases were partially offset by increased commissions due to higher sales.
Research and Development. Our research and development expenses for the nine months ended December 31, 2023 were $7,352,000, which represents a decrease of $978,000, or 11.7%, from the nine months ended December 31, 2022 of $8,330,000. This decrease was primarily due to our cost-cutting measures, which included headcount reduction and a reduction in research and development expenses.
Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts for the nine months ended December 31, 2023 and 2022 were non-cash gains of $2,659,000 and $2,553,000, respectively. This change during the nine months ended December 31, 2023 compared with the nine months ended December 31, 2022 was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in non-cash gains of $4,430,000 and $2,108,000, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in a non-cash loss of $1,771,000 compared with a non-cash gain of $445,000, respectively, due to the changes in their fair values.
Operating Income
Consolidated Operating Income. Our consolidated operating income for the nine months ended December 31, 2023 was $33,902,000, which represents an increase of $21,189,000, or 166.7%, from the nine months ended December 31, 2022 of $12,713,000. This increase was primarily due to higher sales and higher gross profit as discussed above.
Interest Expense
Interest Expense, net. Our interest expense for the nine months ended December 31, 2023 was $45,400,000, which represents an increase of $17,725,000, or 64.0%, from interest expense for the nine months ended December 31, 2022 of $27,675,000. This increase was primarily due to (i) higher interest rates and increased utilization of our accounts receivable discount programs, which have variable interest rates, (ii) higher interest rates on lower average outstanding balances under our credit facility, which also has variable interest rates, and (iii) non-cash interest expense incurred on the Convertible Notes issued on March 31, 2023.
Change in Fair Value of Compound Net Derivative Liability
Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability for the nine months ended December 31, 2023 was a non-cash loss of $1,690,000 associated with the convertible notes issued on March 31, 2023.
Loss on Extinguishment of Debt
Loss on Extinguishment of Debt. Our loss on extinguishment of debt was $168,000 in connection with the repayment of the remaining outstanding balance of our term loans during the nine months ended December 31, 2023.
Provision for Income Taxes
Income Tax. We recorded an income tax expense of $37,226,000, or an effective tax rate of (278.7%), and an income tax benefit of $9,296,000, or an effective tax rate of 62.1%, for the nine months ended December 31, 2023 and 2022, respectively. During the nine months ended December 31, 2023, we recorded a discrete non-cash valuation allowance of $37,461,000 on our U.S. federal and various state deferred tax assets primarily due to recent losses. The change in the valuation allowance resulted from an updated forecast during the nine months ended December 31, 2023. The effective tax rate for the nine months ended December 31, 2023, was primarily impacted by (i) the establishment of a valuation allowance on deferred tax assets that we do not expect to be realized, (ii) foreign income taxed at rates that are different from the federal statutory rate, (iii) the portion of book expense related to convertible notes and derivatives that is not expected to be deductible for tax, and (iv) non-deductible executive compensation under Internal Revenue Code Section 162(m).
Liquidity and Capital Resources
Overview
We had working capital (current assets minus current liabilities) of $154,815,000 and $154,886,000, a ratio of current assets to current liabilities of 1.4:1.0, at December 31, 2023 and March 31, 2023, respectively.
Our primary source of liquidity was from cash generated from operations during the nine months ended December 31, 2023. We believe cash generated from operations, our cash and cash equivalents, use of accounts receivable discount programs, amounts available under our credit facility, and other sources are sufficient to satisfy our working capital needs, and lease and capital expenditure obligations over the next 12 months.
Share Repurchase Program
In August 2018, our board of directors approved an increase in our share repurchase program from $20,000,000 to $37,000,000 of our common stock. As of December 31, 2023, $18,745,000 had been utilized and $18,255,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our credit facility. We retired the 837,007 shares repurchased under this program through December 31, 2023. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.
Cash Flows
The following summarizes cash flows as reflected in the condensed consolidated statements of cash flows:
| | Nine Months Ended December 31, | |
| | 2023 | | | 2022 | |
Cash flows provided by (used in): | | | | | | |
Operating activities | | $ | 48,445,000 | | | $ | (21,428,000 | ) |
Investing activities | | | (420,000 | ) | | | (3,855,000 | ) |
Financing activities | | | (47,646,000 | ) | | | 14,898,000 | |
Effect of exchange rates on cash and cash equivalents | | | 180,000 | | | | (52,000 | ) |
Net increase (decrease) in cash and cash equivalents | | $ | 559,000 | | | $ | (10,437,000 | ) |
Additional Selected Cash flow data:
| | | | | | | | |
Depreciation and amortization | | $ | 8,844,000 | | | $ | 9,322,000 | |
Capital expenditures | | | 462,000 | | | | 3,607,000 | |
Net cash provided by operating activities was $48,445,000 during the nine months ended December 31, 2023 compared with net cash used in operations of $21,428,000 during the nine months ended December 31, 2022. The significant changes in our operating activities reflect (i) the timing of supplier payments compared with the prior year, (ii) continued investments in inventory to support anticipated future demand for our products compared with inventory reduction initiatives in the prior year, and (iii) increased collections of our accounts receivable balances resulting from higher sales during the current year. We continue to manage our working capital to maximize our operating cash flow.
Net cash used in investing activities was $420,000 and $3,855,000 during the nine months ended December 31, 2023 and 2022, respectively. The change in our investing activities primarily resulted from decreased capital expenditures.
Net cash used in financing activities was $47,646,000 during the nine months ended December 31, 2023 compared with net cash provided by financing activities of $14,898,000 during the nine months ended December 31, 2022. The change in our financing activities primarily resulted from (i) the repayment of amounts outstanding under our credit facility of $43,325,000 and (ii) the payment of debt issuance costs incurred in connection with the amendments to our credit facility and convertible notes during the nine months ended December 31, 2023.
Capital Resources
Credit Facility
We are party to a $268,620,000 senior secured financing (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain restrictions, and a $30,000,000 term loan facility (the “Term Loans”). Prior to the eighth amendment discussed below, the loans under the Credit Facility were scheduled to mature on May 28, 2026. The lenders have a security interest in substantially all of our assets.
On August 3, 2023, we entered into a seventh amendment to the Credit Facility, which among other things, (i) permitted us to repay our outstanding balance of Term Loans, (ii) permitted the exclusion of quarterly principal payments of Term Loans from the fixed charge coverage ratio (including retrospectively for the prior periods) for all quarters beginning June 30, 2023, (iii) reset the fixed charge coverage ratio financial covenant level for the quarters ending September 30, 2023 and December 31, 2023, (iv) eliminated the senior leverage ratio financial covenant effective with the quarter ended June 30, 2023, (v) extended the minimum undrawn availability financial covenant through the delivery of the June 30, 2024 compliance certificate, and (vi) excluded the amount of all amendment fees and expenses incurred in connection with this amendment as well as prior unamortized fees associated with the Term Loans from bank EBITDA and the fixed charge coverage ratio financial covenant.
On August 3, 2023, we repaid the remaining outstanding balance of our Term Loans and recorded a loss on extinguishment of debt for the remaining unamortized debt issuance costs of $168,000 in the condensed consolidated statement of operations.
On December 12, 2023, we entered into an eighth amendment to the Credit Facility, which among other things, (i) extended the maturity date to December 12, 2028 from May 28, 2026, (ii) amended the definition of “Applicable Margin” to provide for a pricing grid, with the Applicable Margin for Term SOFR loans ranging from 2.75% to 3.25% and the Applicable Margin for base rate loans ranging from 1.75% to 2.25%, in each case based on average daily undrawn availability for the most recently completed calendar quarter, (iii) amended the existing fixed charge coverage ratio financial covenant that is only tested if undrawn availability (which may include up to $8,000,000 of suppressed availability) is less than 22.5% of the aggregate revolving commitments, and (iv) amended the definitions of Consolidated EBITDA and fixed charge coverage ratio and certain component definitions used therein.
We had $115,000,000 and $145,200,000 outstanding under the Revolving Facility at December 31, 2023 and March 31, 2023, respectively. In addition, $6,370,000 was outstanding for letters of credit at December 31, 2023. At December 31, 2023, after certain contractual adjustments, $114,168,000 was available under the Revolving Facility. The interest rate on our Revolving Facility was 8.71% and 8.13% respectively, at December 31, 2023 and March 31, 2023, respectively.
The Credit Facility, as amended, requires us to maintain a minimum fixed charge coverage ratio if undrawn availability is less than 22.5% of the aggregate revolving commitments and a specified minimum undrawn availability. At December 31, 2023, the undrawn availability was greater than the 22.5% threshold, therefore, the fixed charge coverage ratio financial covenant was not required to be tested. We were in compliance with these covenants as of December 31, 2023.
Convertible Notes
On March 31, 2023, we entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. The Convertible Notes have an initial conversion price of approximately $15.00 per share of common stock. (“Conversion Option”). Unless and until we deliver a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of our common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, we may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, we may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price.
On June 8, 2023, we entered into the first amendment to the Note Purchase Agreement, which among other things, removed a provision that specified the Purchasers would be entitled to receive a dividend or distribution payable in certain circumstances. This amendment was effective as of March 31, 2023.
On August 1, 2023, we entered into the second amendment to the Note Purchase Agreement, which amended the definition of “Permitted Restricted Payments” to permit the prepayment of our Term Loans.
In connection with the Note Purchase Agreement, we entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the Monte Carlo simulation model, was zero at December 31, 2023 and March 31, 2023.
The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within convertible note, related party in the condensed consolidated balance sheets at December 31, 2023 and March 31, 2023. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model was a liability of $13,500,000 and $10,400,000, and an asset of $3,380,000 and $1,970,000 at December 31, 2023 and March 31, 2023, respectively. During the three and nine months ended December 31, 2023, we recorded $1,160,000 and $1,690,000, respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statement of operations and condensed consolidated statement of cash flows.
The Convertible Notes also contain additional features, such as, default interest and options related to a fundamental transaction, which were not separately accounted for as the value of such features were not material at December 31, 2023 and March 31, 2023.
Accounts Receivable Discount Programs
We use accounts receivable discount programs offered by certain customers and their respective banks. Under these programs, we have options to sell those customers’ receivables to those banks at a discount to be agreed upon at the time the receivables are sold. These discount arrangements allow us to accelerate receipt of payment on customers’ receivables. While these arrangements have reduced our working capital needs, there can be no assurance that these programs will continue in the future. Interest expense resulting from these programs would increase if interest rates rise, if utilization of these discounting arrangements expands, if customers extend their payment to us, or if the discount period is extended to reflect more favorable payment terms to customers.
The following is a summary of the accounts receivable discount programs:
| | Nine Months Ended December 31, | |
| | 2023 | | | 2022 | |
Receivables discounted | | $ | 465,073,000 | | | $ | 428,868,000 | |
Weighted average number of days collection was accelerated | | | 334 | | | | 323 | |
Annualized weighted average discount rate | | | 6.8 | % | | | 5.0 | % |
Amount of discount recognized as interest expense | | $ | 29,395,000 | | | $ | 19,131,000 | |
Capital Expenditures and Commitments
Capital Expenditures
Our total capital expenditures, including finance leases and non-cash capital expenditures were $559,000 and $3,632,000 for the nine months ended December 31, 2023 and 2022, respectively. These capital expenditures primarily include the purchase of equipment for our operations. We expect to incur approximately $1,500,000 of capital expenditures during fiscal 2024 to support our operations. We have used and expect to continue using our working capital and additional capital lease obligations to finance these capital expenditures.
Related Party Transactions
Lease
In December 2022, we entered into an operating lease for our 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. The lease, which commenced January 1, 2023, had an initial term of one year with a base rent of approximately $27,000 per month and included options to renew for up to four years. In November 2023, we exercised one of these options to renew for an additional one-year period. The rent expense recorded for the related party lease was $81,000 and $243,000 for the three and nine months ended December 31, 2023.
Convertible Note and Election of Director
In connection with the issuance and sale of our Convertible Notes on March 31, 2023, the Board appointed Douglas Trussler, a co-founder of Bison Capital in 2001, to the Board. Mr. Trussler’s compensation will be consistent with our previously disclosed standard compensation practices for non-employee directors, which are described in our Definitive Proxy Statement, filed with the SEC on July 28, 2023.
Litigation
We are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business, and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such.
Critical Accounting Policies
There have been no material changes to, except as noted below, our critical accounting policies and estimates that are presented in our Annual Report on Form 10-K for the year ended March 31, 2023, which was filed on June 14, 2023.
Recently Adopted Accounting Pronouncements
Supplier Finance Programs
In September 2022, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50) Disclosure of Supplier Finance Program Obligations. This standard requires qualitative and quantitative disclosures sufficient to enable users of the financial statements to understand the nature, activity during the period, changes from period to period and potential magnitude of supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022.
During the three months ended December 31, 2023, we launched a supplier finance program as part of our ongoing efforts to improve cash flow and liquidity. This program allows certain of our suppliers to sell their receivables due from us to a participating financial institution at the sole discretion of both the supplier and the financial institution. The program is administered by a third party. We have no economic interest in the sale of these receivables and no direct relationship with the financial institution. Payments to the third-party administrator are based on services rendered and are not on related to the volume or number of financing agreements between suppliers, financial institution, and the third-party administrator. We are not a party to agreements negotiated between participating suppliers and the financial institution. Our obligations to our suppliers, including amounts due and payment terms, are not affected by a supplier's decision to participate in this program. We do not provide guarantees and there are no assets pledged to the financial institution or the third-party administrator for the committed payment in connection with this program. Any amounts confirmed as outstanding supplier invoices are included within accounts payable on the condensed consolidated balance sheets. As of December 31, 2023, we had no outstanding supplier obligations confirmed under this program.
Accounting Pronouncements Not Yet Adopted
Disclosure Improvements
In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This standard was issued in response to the SEC’s disclosure update and simplification initiative, which affects a variety of topics within the Accounting Standards Codification. The amendments apply to all reporting entities within the scope of the affected Topics unless otherwise indicated. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. We are currently evaluating the impact this guidance will have on our financial statement disclosures.
Reportable Segment Disclosures
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). This standard requires us to disclose significant segment expenses that are regularly provided to the CODM and are included within each reported measure of segment operating results. The standard also requires us to disclose the total amount of any other items included in segment operating results, which were not deemed to be significant expenses for separate disclosure, along with a qualitative description of the composition of these other items. In addition, the standard also requires disclosure of the CODM’s title and position, as well as detail on how the CODM uses the reported measure of segment operating results to evaluate segment performance and allocate resources. The standard also aligns interim segment reporting disclosure requirements with annual segment reporting disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). This standard requires us to provide further disaggregated income tax disclosures for specific categories on the effective tax rate reconciliation, as well as additional information about federal, state/local and foreign income taxes. The standard also requires us to annually disclose our income taxes paid (net of refunds received), disaggregated by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be applied prospective basis, although optional retrospective application is permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
There have been no material changes in market risk from the information provided in Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K as of March 31, 2023, which was filed with the SEC on June 14, 2023.
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
We have established disclosure controls and procedures designed to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management, including our chief executive officer, chief financial officer, and chief accounting officer, as appropriate to allow timely decisions regarding required disclosures.
Under the supervision and with the participation of management, including our chief executive officer, chief financial officer, and chief accounting officer, we have conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on this evaluation, our chief executive officer, chief financial officer, and chief accounting officer concluded that MPA’s disclosure controls and procedures were effective as of December 31, 2023.
Inherent Limitations on Effectiveness of Controls
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).
Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America, applying certain estimates and judgments as required.
Internal control over financial reporting includes those policies and procedures that:
1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II — OTHER INFORMATION
We are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business, and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such.
There have been no material changes in the risk factors set forth in Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended March 31, 2023, filed on June 14, 2023.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Limitation on Payment of Dividends and Share Repurchases
The Credit Facility currently permits the payment of up to $30,000,000 of dividends and share repurchases for fiscal year 2024, subject to pro forma compliance with amended financial covenants.
Purchases of Equity Securities by the Issuer
Shares repurchased during the three months ended December 31, 2023 were as follows:
Periods | | Total Number of Shares Purchased | | | Average Price Paid Per Share | | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1) | |
| | | | | | | | | | | | |
October 1 - October 31, 2023: | | | | | | | | | | | | |
Open market and privately negotiated purchases | | | - | | | $ | - | | | | - | | | $ | 18,255,000 | |
November 1 - November 30, 2023: | | | | | | | | | | | | | | | | |
Open market and privately negotiated purchases | | �� | - | | | $ | - | | | | - | | | | 18,255,000 | |
December 1 - December 31, 2023: | | | | | | | | | | | | | | | | |
Open market and privately negotiated purchases | | | - | | | $ | - | | | | - | | | | 18,255,000 | |
Total | | | 0 | | | | | | | | 0 | | | $ | 18,255,000 | |
| (1) | As of December 31, 2023, $18,745,000 had been utilized and $18,255,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our Credit Facility. We retired the 837,007 shares repurchased under this program through December 31, 2023. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions. |
Item 3. | Defaults Upon Senior Securities |
None.